Molecular characteristics of glioblastoma subtypes according to methylation, expression, mutation, copy number variations patterns, and clinical outcome.
IDH1/IDH2 status
Wild type
Mutated
MGMT
Mostly unmethylated
Methylated
Methylation status
CIMP−
CIMP+
Mutations
TERT
ATRX-TP53
CIC-FUBP1
CNV
EGFR+
NF1−
PDGFRA+
PDGFRA+; 1p19q−
Molecular subtype
Classical
Mesenchymal
Neural
Proneural
Outcome
Very poor outcome
Significantly improved outcome
Significantly improved outcome. Better response to TMZ than 1p19q+